Indian pharma industry likely to grow to $130 bn by 2030 Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The IDMA is working closely with the Government of India on PLI 2.0. A large part of imported medicine and equipment will be manufactured locally, decreasing dependence on imports and giving healthcare security to India. India is moving from being a generic manufacturing giant to value addition. Innovation, technology and entrepreneurship will drive India towards this said Dr Viranchi Shah, National President, Indian Drug Manufacturers Association., The IDMA is working closely with the Government of India on PLI 2.0. A large part of imported medicine and equipment will be manufactured locally, decreasing dependence on imports and giving healthcare security to India. India is moving from being a generic manufacturing giant to value addition. Innovation, technology and entrepreneurship will drive India towards this said Dr Viranchi Shah, National President, Indian Drug Manufacturers Association., , Read More